Dianomi Therapeutics Receives $3M from Ligand Pharmaceuticals

Dianomi Therapeutics Receives $3M from Ligand Pharmaceuticals

He has served on the boards of directors of several private and public healthcare companies and currently is a board member of Eirion Therapeutics, Inc. William Murphy, Ph.D., is Dianomi’s Chief…

3
Like
Save

Comments

Write a comment

*